CN103804294B - Synthetic method of 7 or 9-chloro-4,5-dihydro-1hydro-benzo[b]azepine-2(3hydro)-one - Google Patents

Synthetic method of 7 or 9-chloro-4,5-dihydro-1hydro-benzo[b]azepine-2(3hydro)-one Download PDF

Info

Publication number
CN103804294B
CN103804294B CN201410035968.8A CN201410035968A CN103804294B CN 103804294 B CN103804294 B CN 103804294B CN 201410035968 A CN201410035968 A CN 201410035968A CN 103804294 B CN103804294 B CN 103804294B
Authority
CN
China
Prior art keywords
hydrogen
chloro
benzo
dihydro
azatropylidene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201410035968.8A
Other languages
Chinese (zh)
Other versions
CN103804294A (en
Inventor
魏庚辉
李仟
宁兆伦
郭鹏
谢国斌
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astatech (Chengdu) biological pharmaceutical Limited by Share Ltd
Original Assignee
ASTATECH (CHENGDU) PHARMACEUTICAL Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ASTATECH (CHENGDU) PHARMACEUTICAL Co Ltd filed Critical ASTATECH (CHENGDU) PHARMACEUTICAL Co Ltd
Priority to CN201410035968.8A priority Critical patent/CN103804294B/en
Publication of CN103804294A publication Critical patent/CN103804294A/en
Application granted granted Critical
Publication of CN103804294B publication Critical patent/CN103804294B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention belongs to the organic synthesis field and specifically relates to a synthetic method of 7 or 9-chloro-4,5-dihydro-1hydro-benzo[b]azepine-2(3hydro)-one. The synthetic method is used for solving the technical problems that the existing synthetic method is low in yield, high in cost, difficult in aftertreatment purification, difficult in raw material getting and not applicable to enlarged production. The technical scheme for solving the technical problem is to provide the synthetic method of 7 or 9-chloro-4,5-dihydro-1hydro-benzo[b]azepine-2(3hydro)-one, and the synthetic method comprises the steps of reacting o- or para-chloroaniline with succinic anhydride, carrying out intramolecular Friedel-Craft ring closing reaction of the reaction product, and then carrying out Huangminglong reduction reaction to obtain the 7 or 9-chloro-4,5-dihydro-1hydro-benzo[b]azepine-2(3hydro)-one. The invention provides a new method which is short in steps, high in total yield and free of use of expensive noble metal catalyst.

Description

7 or the synthetic method of chloro-4,5-dihydro-1 hydrogen-benzo [b] azatropylidene-2 (3 hydrogen)-one of 9-
Technical field
The invention belongs to organic synthesis field, be specifically related to the synthetic method of 7 or chloro-4,5-dihydro-1 hydrogen-benzo [b] azatropylidene-2 (3 hydrogen)-one of 9-.
Background technology
Azatropylidene-2-ketone is widely used in new drug development as the core fragment of Na-ion channel blocker medicine according to the literature.Especially 7 or 9 chloro-dihydrobenzo [b] azatropylidene-2-ketone can realize to drug molecule as the functional group continuing to participate in reaction due to chlorine multiple modification, and it applies extensive especially in new drug development.But mostly the synthetic method of this compounds is to become oxime rearrangement to realize with azido-or azanol by naphthalenone at present, and the use of azido-exists dangerously explosive danger, and the method for resetting often has isomer to produce, separation difficulty, and cost is very high simultaneously.Another method first builds the allylic fragrant acrylamide structure in ortho position, then close ring by the metathesis of alkene, the more saturated double bond of hydrogenation obtains target product, but to there is raw material in the method be not easy to obtain, total recovery is low, and with the noble metal catalyst of rare costliness.
The first reported scheme be by, chloro-3,4-dihydronaphthalene-1 (2 hydrogen)-one of 6-are set out, and oxammonium hydrochloride reaction generate oxime; Then reset through Beckmann and obtain chloro-4,5-dihydro-1 hydrogen-benzo [b] azatropylidene-2 (3 hydrogen)-one of 7-(see Journal of OrganicChemistry; Vol.76; Nb.12; (2011); P.5123-5131).But there is following problem in the method: (1) Beckmann resets and inherently has isomer appearance, target compound reaction isomer ratios almost 1:1(52%:47% to we need), this will reduce yield greatly, make separation and purification very difficult simultaneously, produce amplification efficiency low; (2) polyphosphoric acid (PPA) or the vitriol oil will be used, unfriendly to environment; (3) program use chloro-3,4-dihydronaphthalene-1 (2 hydrogen)-one of initial feed 6-expensive, be not easy to obtain, often to be reacted more than five steps by tetraline and just can obtain.Its reaction formula is as follows:
The reported scheme of the second is with 2,6 or 2, and 4 have the aniline of different halogen substiuted to be that starting raw material is (see Tetrahedron Letters; Vol.50; Nb.17; (2009); P.1911-1913).First be the aniline that active high halogen and allyltin reagent linked reaction obtain 2 allyl groups replacements; Then amino and acrylate chloride generation acylation reaction obtains acrylamide product; Then there is the metathesis ring closure reaction of alkene in two ethylene linkages under Grubbs catalyst action, obtains the azatropylidene-2-ketone being with double bond; Finally by reduction such as hydrogenations, double bond is saturated, obtain 7 or fluoro-4,5-dihydro-1 hydrogen-benzo [b] azatropylidene-2 (3 hydrogen)-one of 9-.There is following problem in the method: (1) starting raw material is not easy to obtain, and two ortho positions amino on phenyl ring or ortho para want diverse halogen substiuted, and synthesis ratio is more difficult; (2) coupling of the first step tin reagent and olefin metathesis ring closure reaction all will use expensive catalyzer; (3) when last double-bond hydrogenation is saturated, likely simultaneously by the halogen displacement Cheng Qing of 7 or 9.Program total recovery is very low, and waste production is excessive, is not suitable for amplifying producing.Its reaction formula is as follows:
Summary of the invention
The technical problem to be solved in the present invention is that existing synthetic method yield is low, cost is high, aftertreatment purification difficult, and raw material is not easy to obtain, and is not suitable for amplifying producing.
The scheme that the present invention solves the problems of the technologies described above is to provide the synthetic method of a kind of 7 or chloro-4,5-dihydro-1 hydrogen-benzo [b] azatropylidene-2 (3 hydrogen)-one of 9-.The synthetic route of the method is as follows: Ortho-Chloro aniline or p-Chlorobenzoic acid amide and Succinic anhydried are reacted, and obtains 4-(2 or 4-chloroanilino)-4-ketobutyric acid; 4-(2 or 4-chloroanilino)-4-ketobutyric acid, by Friedel-Crafts reaction (Friedel-Crafts reaction) in molecule, obtains 7 or chloro-3,4-dihydro-1 hydrogen-benzo [b] azatropylidene-2, the 5-diketone of 9-; 7 or chloro-3,4-dihydro-1 hydrogen-benzo [b] azatropylidene-2, the 5-diketone of 9-through Huang Min-lon reduction, obtain 7 or chloro-4,5-dihydro-1 hydrogen-benzo [b] azatropylidene-2 (3 hydrogen)-one of 9-.
Wherein, above-mentioned 7 or the structural formula of chloro-4,5-dihydro-1 hydrogen-benzo [b] azatropylidene-2 (3 hydrogen)-one of 9-as follows:
Above-mentioned 7 or the reaction formula of synthetic method of chloro-4,5-dihydro-1 hydrogen-benzo [b] azatropylidene-2 (3 hydrogen)-one of 9-as follows:
Above-mentioned 7 or the synthetic method of chloro-4,5-dihydro-1 hydrogen-benzo [b] azatropylidene-2 (3 hydrogen)-one of 9-, comprise following operation steps:
A, Ortho-Chloro aniline or p-Chlorobenzoic acid amide and Succinic anhydried react: be dissolved in organic solvent by Ortho-Chloro aniline or p-Chlorobenzoic acid amide and Succinic anhydried, then heating reflux reaction 4 ~ 8 hours, reaction terminates rear removing organic solvent, adds the hydrochloric acid of cold 1N, stir 10 ~ 15 minutes in resistates; Filter out solid, obtain 4-(2 or 4-chloroanilino)-4-ketobutyric acid;
Friedel-Crafts reaction in B, molecule: above-mentioned 4-(2 or 4-chloroanilino)-4-ketobutyric acid is dissolved in ethylene dichloride, adds aluminum trichloride (anhydrous), then 55 ~ 70 degree of reactions 4 ~ 6 hours; Then by above-mentioned reaction solution cool to room temperature, control temperature is no more than 35 degree, adds the hydrochloric acid of 3N ~ 6N; Separatory retains organic phase again, and then aqueous phase ethylene dichloride extracts, and merges organic phase, organic phase after drying, solids removed by filtration, organic phase is concentrated except desolventizing, obtains 7 or chloro-3,4-dihydro-1 hydrogen-benzo [b] azatropylidene-2, the 5-diketone of 9-;
C, Huang Min-lon reduction: by 7 or 150 ~ 170 degree of reactions 4 ~ 6 hours in ethylene glycol of chloro-3,4-dihydro-1 hydrogen-benzo [b] azatropylidene-2, the 5-diketone of 9-, hydrazine hydrate and potassium hydroxide; Then reaction solution is down to room temperature, adds salt solution, filter and obtain 7 or chloro-4,5-dihydro-1 hydrogen-benzo [b] azatropylidene-2 (3 hydrogen)-one of 9-.
Wherein, the mol ratio of the Ortho-Chloro aniline described in steps A or p-Chlorobenzoic acid amide and Succinic anhydried is 1:0.95 ~ 1.05.
Wherein, the organic solvent described in steps A is any one in ethylene dichloride, tetrahydrofuran (THF) or glycol dimethyl ether.
Wherein, 4-described in step B (2 or 4-chloroanilino)-4-ketobutyric acid and anhydrous AlCl 3mol ratio be 1:1.0 ~ 1.5.
Wherein, the mol ratio of chloro-3,4-dihydro-1 hydrogen-benzo [b] azatropylidene-2, the 5-diketone of 7 described in step C or 9-, hydrazine hydrate and potassium hydroxide is 1:5.0 ~ 7.0:1.3 ~ 1.8.
The present invention for starting raw material, just can obtain 7 or 9-chloro-4,5-dihydro-1 hydrogen-benzo [b] azatropylidene-2 (3 hydrogen)-one by means of only 3 steps reactions with Ortho-Chloro aniline that is cheap, that be easy to get or p-Chlorobenzoic acid amide and Succinic anhydried.Preparation method provided by the invention avoids the isomeric side-product of Beckmann rearrangement, and yield is high, simple to operate, and total recovery is higher, and product is purified convenient, and cost is lower, is applicable to suitability for industrialized production.
Specific embodiment
7 or the synthetic method of chloro-4,5-dihydro-1 hydrogen-benzo [b] azatropylidene-2 (3 hydrogen)-one of 9-, comprise following operation steps:
A, Ortho-Chloro aniline or p-Chlorobenzoic acid amide and Succinic anhydried react: be dissolved in organic solvent by Ortho-Chloro aniline or p-Chlorobenzoic acid amide and Succinic anhydried, then heating reflux reaction 4 ~ 8 hours, reaction terminates rear removing organic solvent, adds the hydrochloric acid of cold 1N, stir 10 ~ 15 minutes in resistates; Filter out solid, obtain 4-(2 or 4-chloroanilino)-4-ketobutyric acid;
Friedel-Crafts reaction in B, molecule: above-mentioned 4-(2 or 4-chloroanilino)-4-ketobutyric acid is dissolved in ethylene dichloride, adds anhydrous AlCl 3, then 55 ~ 70 degree of reactions 4 ~ 6 hours; Then by above-mentioned reaction solution cool to room temperature, control temperature is no more than 35 degree, adds the hydrochloric acid of 3N ~ 6N; Separatory retains organic phase again, and then aqueous phase ethylene dichloride extracts, and merges organic phase, organic phase after drying, solids removed by filtration, organic phase is concentrated except desolventizing, obtains 7 or chloro-3,4-dihydro-1 hydrogen-benzo [b] azatropylidene-2, the 5-diketone of 9-;
C, Huang Min-lon reduction: by 7 or 150 ~ 170 degree of reactions 4 ~ 6 hours in ethylene glycol of chloro-3,4-dihydro-1 hydrogen-benzo [b] azatropylidene-2, the 5-diketone of 9-, hydrazine hydrate and potassium hydroxide; Then reaction solution is down to room temperature, adds salt solution, filter and obtain 7 or chloro-4,5-dihydro-1 hydrogen-benzo [b] azatropylidene-2 (3 hydrogen)-one of 9-.
Wherein, the mol ratio of the Ortho-Chloro aniline described in steps A or p-Chlorobenzoic acid amide and Succinic anhydried is 1:0.95 ~ 1.05.When the mol ratio of Ortho-Chloro aniline or p-Chlorobenzoic acid amide and Succinic anhydried is in above-mentioned scope, raw material just reacts completely, and product purity is higher.
Wherein, the organic solvent described in steps A is any one in ethylene dichloride, tetrahydrofuran (THF) or glycol dimethyl ether.
Wherein, 4-described in step B (2 or 4-chloroanilino)-4-ketobutyric acid and anhydrous AlCl 3mol ratio be 1:1.0 ~ 1.5.AlCl 3be less than 1.0 equivalent reactions not complete, have impurity more than 1.5 equivalents and generate.
Wherein, the mol ratio of chloro-3,4-dihydro-1 hydrogen-benzo [b] azatropylidene-2, the 5-diketone of 7 described in step C or 9-, hydrazine hydrate and potassium hydroxide is 1:5.0 ~ 7.0:1.3 ~ 1.8.Hydrazine hydrate is less than 5 equivalents and stirs difficulty, does not have impact after being greater than 7 equivalents on reaction, but uneconomical; It is not complete that potassium hydroxide is less than 1.3 equivalent reactions, do not affect after being greater than 1.8 equivalents on reaction, but uneconomical.
The synthesis of chloro-4,5-dihydro-1 hydrogen-benzo [b] azatropylidene-2 (3 hydrogen)-one of embodiment 17-:
(1) 127g4-chloroaniline and 100g Succinic anhydried are dissolved in 600ml ethylene dichloride, heating reflux reaction 6 hours.Remove ethylene dichloride under reduced pressure after reaction terminates, in resistates, add the hydrochloric acid of the cold 1N of 300mL, stir 10 minutes; Filter to obtain white solid 4-(4-chloroanilino)-4-ketobutyric acid 212g, yield 93.4%.H 1NMR(300MHz,DMSO-d6):δ2.61(m,4H),7.39~7.45(d,J=7.2Hz,2H),7.55~7.48(d,J=7.2Hz,2H),10.05(br,1H),11.98(br,1H)。
(2) 200g4-(4-chloroanilino)-4-ketobutyric acid is dissolved in 1.2L ethylene dichloride, adds the anhydrous AlCl of 150g 3.This mixture was 60 degree of reacting by heating 4 hours.Reaction solution cool to room temperature, control temperature is no more than 35 degree, adds the hydrochloric acid of 1L3N under stirring in batches.Separatory, then aqueous phase 600mL ethylene dichloride extraction, merges organic phase.Dried over sodium sulfate organic phase, then filtering and concentrating, obtain chloro-3,4-dihydro-1 hydrogen-benzo [b] azatropylidene-2, the 5-diketone 168g of off-white color solid 7-, yield 91.3%.H 1NMR(300MHz,CDCl 3):δ2.91(m,4H),7.24~7.26(m,1H),7.42~7.52(m,2H)。
(3) chloro-3,4-dihydro-1 hydrogen-benzo [b] azatropylidene-2, the 5-diketone of 150g7-, 85% hydrazine hydrate 165g, KOH60g once adds in 500mL ethylene glycol.Stir after nitrogen replacement and be warming up to 165 degree and react 4 hours.Reaction mixture is cooled to room temperature, under stirring state, is added by mixture in 4L salt solution, has a large amount of off-white color solid to separate out.Collecting by filtration white solid, dry chloro-4,5-dihydro-1 hydrogen-benzo [b] azatropylidene-2 (3 hydrogen) the-one 119g of product 7-, productive rate 85%, HPLC detects purity and is greater than 98%, and single contaminant is less than 0.5%.H 1NMR(DMSO-d6):δ9.56(s,1H,NH),6.96~7.36(3H,aromatics),2.67~2.70(t,2H,CH 2),2.06~2.18(m,4H,CH 2CH 2)。
The synthesis of chloro-4,5-dihydro-1 hydrogen-benzo [b] azatropylidene-2 (3 hydrogen)-one of embodiment 29-
(1) 64g4-chloroaniline and 50g Succinic anhydried are dissolved in 300mL ethylene dichloride, then heating reflux reaction 6 hours.Remove ethylene dichloride under reduced pressure after reaction terminates, in resistates, add the hydrochloric acid of the cold 1N of 150mL, stir 10 minutes; Filter to obtain white solid 4-(2-chloroanilino)-4-ketobutyric acid 108g, yield 93.7%.H 1NMR(300MHz,DMSO-d6):δ2.60(m,4H),7.39~7.59(m,4H),10.04(br,1H),12.35(br,1H)。
(2) 100g4-(2-chloroanilino)-4-ketobutyric acid is dissolved in 600mL ethylene dichloride, adds the anhydrous AlCl of 75g 3.This mixture was 60 degree of reacting by heating 4 hours.Reaction solution cool to room temperature, control temperature is no more than 35 degree, adds the hydrochloric acid of 500mL3N under stirring in batches.Separatory, then aqueous phase 300mL ethylene dichloride extraction, merges organic phase.Dried over sodium sulfate organic phase, then filtering and concentrating, obtain chloro-3,4-dihydro-1 hydrogen-benzo [b] azatropylidene-2, the 5-diketone 85g of off-white color solid 9-, yield 91.4%.H 1NMR(300MHz,CDCl3):2.93(m,4H),7.42~7.62(m,3H)。
(3) chloro-3,4-dihydro-1 hydrogen-benzo [b] azatropylidene-2, the 5-diketone of 76g9-, 85% hydrazine hydrate 83g, KOH31g once adds in 255mL ethylene glycol.Stir after nitrogen replacement and be warming up to 165 degree and react 4 hours.Reaction mixture is cooled to room temperature, under stirring state, is added by mixture in 2L salt solution, has a large amount of off-white color solid to separate out.Collecting by filtration white solid, dry chloro-4,5-dihydro-1 hydrogen-benzo [b] azatropylidene-2 (3 hydrogen) the-one 60g of product 9-, productive rate 85%, HPLC detects purity and is greater than 98.5%, and single contaminant is less than 0.5%.H 1NMR(DMSO-d6):δ9.53(s,1H,NH),7.40~7.58(m,3H),2.65~2.69(t,2H,CH 2),2.04~2.16(m,4H,CH 2CH 2)。
Preparation method's yield provided by the invention is high, simple to operate, and total recovery is higher, and product is purified convenient, and cost is lower, is applicable to suitability for industrialized production.

Claims (5)

1.7 or the synthetic method of chloro-4,5-dihydro-1 hydrogen-benzo [b] azatropylidene-2 (3 hydrogen)-one of 9-, comprise the following steps:
A, Ortho-Chloro aniline or p-Chlorobenzoic acid amide and Succinic anhydried react: be dissolved in organic solvent by Ortho-Chloro aniline or p-Chlorobenzoic acid amide and Succinic anhydried, then heating reflux reaction 4 ~ 8 hours, reaction terminates rear removing organic solvent, adds the hydrochloric acid of cold 1N, stir 10 ~ 15 minutes in resistates; Filter out solid, obtain 4-(2 or 4-chloroanilino)-4-ketobutyric acid;
Friedel-Crafts reaction in B, molecule: above-mentioned 4-(2 or 4-chloroanilino)-4-ketobutyric acid is dissolved in ethylene dichloride, adds aluminum trichloride (anhydrous), then 55 ~ 70 DEG C of reactions 4 ~ 6 hours; Then by above-mentioned reaction solution cool to room temperature, control temperature is no more than 35 DEG C, adds the hydrochloric acid of 3N ~ 6N; Separatory retains organic phase again, and then aqueous phase ethylene dichloride extracts, and merges organic phase, organic phase after drying, solids removed by filtration, organic phase is concentrated except desolventizing, obtains 7 or chloro-3,4-dihydro-1 hydrogen-benzo [b] azatropylidene-2, the 5-diketone of 9-;
C, Huang Min-lon reduction: 7 or chloro-3,4-dihydro-1 hydrogen-benzo [b] azatropylidene-2, the 5-diketone of 9-, ethylene glycol, hydrazine hydrate and potassium hydroxide react 4 ~ 6 hours at 150 ~ 170 DEG C; Reaction solution is down to room temperature, adds salt solution, filter, obtain 7 or chloro-4,5-dihydro-1 hydrogen-benzo [b] azatropylidene-2 (3 hydrogen)-one of 9-.
2. according to claim 17 or 9-chloro-4, the synthetic method of 5-dihydro-1 hydrogen-benzo [b] azatropylidene-2 (3 hydrogen)-one, is characterized in that: the mol ratio of the Ortho-Chloro aniline described in steps A or p-Chlorobenzoic acid amide and Succinic anhydried is 1:0.95 ~ 1.05.
3. according to claim 17 or 9-chloro-4, the synthetic method of 5-dihydro-1 hydrogen-benzo [b] azatropylidene-2 (3 hydrogen)-one, is characterized in that: the organic solvent described in steps A is any one in ethylene dichloride, tetrahydrofuran (THF) or glycol dimethyl ether.
4. according to claim 17 or 9-chloro-4, the synthetic method of 5-dihydro-1 hydrogen-benzo [b] azatropylidene-2 (3 hydrogen)-one, is characterized in that: the mol ratio of 4-described in step B (2 or 4-chloroanilino)-4-ketobutyric acid and aluminum trichloride (anhydrous) is 1:1.0 ~ 1.5.
5. according to claim 17 or 9-chloro-4, the synthetic method of 5-dihydro-1 hydrogen-benzo [b] azatropylidene-2 (3 hydrogen)-one, it is characterized in that: 7 described in step C or 9-chloro-3, the mol ratio of 4-dihydro-1 hydrogen-benzo [b] azatropylidene-2,5-diketone, hydrazine hydrate and potassium hydroxide is 1:5.0 ~ 7.0:1.3 ~ 1.8.
CN201410035968.8A 2014-01-24 2014-01-24 Synthetic method of 7 or 9-chloro-4,5-dihydro-1hydro-benzo[b]azepine-2(3hydro)-one Active CN103804294B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410035968.8A CN103804294B (en) 2014-01-24 2014-01-24 Synthetic method of 7 or 9-chloro-4,5-dihydro-1hydro-benzo[b]azepine-2(3hydro)-one

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410035968.8A CN103804294B (en) 2014-01-24 2014-01-24 Synthetic method of 7 or 9-chloro-4,5-dihydro-1hydro-benzo[b]azepine-2(3hydro)-one

Publications (2)

Publication Number Publication Date
CN103804294A CN103804294A (en) 2014-05-21
CN103804294B true CN103804294B (en) 2015-04-01

Family

ID=50701733

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410035968.8A Active CN103804294B (en) 2014-01-24 2014-01-24 Synthetic method of 7 or 9-chloro-4,5-dihydro-1hydro-benzo[b]azepine-2(3hydro)-one

Country Status (1)

Country Link
CN (1) CN103804294B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109400533A (en) * 2018-11-07 2019-03-01 亳州学院 A kind of synthetic method of hydrochloric acid conivaptan key intermediate
CN113636977B (en) * 2021-09-01 2022-12-20 温州大学 Synthesis method of 2-aryl benzazepine and derivatives thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102174016A (en) * 2011-03-02 2011-09-07 宁波人健药业集团有限公司 Method for preparing 7-chloro-2,3,4,5-tetrahydro-1H-1-benzoazepine-2,5-diketone
CN103288709A (en) * 2013-05-17 2013-09-11 安徽世华化工有限公司 Synthesis method of 5-fluorine-indol-2-ketone

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102174016A (en) * 2011-03-02 2011-09-07 宁波人健药业集团有限公司 Method for preparing 7-chloro-2,3,4,5-tetrahydro-1H-1-benzoazepine-2,5-diketone
CN103288709A (en) * 2013-05-17 2013-09-11 安徽世华化工有限公司 Synthesis method of 5-fluorine-indol-2-ketone

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
"A Facile Synthesis of 1,3,4,6-Tetrahydro-1,6-benzodiazocine-2,5-diones";D.V. Jarikote等;《Russian Journal of Organic Chemistry》;20041231;第40卷(第4期);第575页Scheme1 *
"Synthesis of Tetrahydrobenzazepinesulfonamides and Their Rearrangement to Diarylsulfones";Hui Hui等;《Synthetic Communications》;20061231(第36期);第357页Scheme1 *

Also Published As

Publication number Publication date
CN103804294A (en) 2014-05-21

Similar Documents

Publication Publication Date Title
EP2880017B1 (en) Process and intermediates for preparing integrase inhibitors
CN103804294B (en) Synthetic method of 7 or 9-chloro-4,5-dihydro-1hydro-benzo[b]azepine-2(3hydro)-one
IL179832A (en) Process for the synthesis of terbinafine and derivatives thereof
CN107235891B (en) Preparation method of 4-bromocarbazole
CN1679586A (en) Novel synthesis and crystallization of piperazine ring-containing compounds
CN109608360B (en) Method for preparing 1-amino-2-cyanocyclopentene
CN101973897B (en) Synthesis method of valdoxan intermediate 2-(7-methoxy-1-naphthyl)ethylamine
CN101967102B (en) Synthesizing method of N,N-diethyl-3,7-dimethyl-(E)-2,6-octadiene-1-amine
CN102702196B (en) Method for synthesizing 3-methyl-7-diazaindene
CN105085513B (en) The method that one kind prepares (R) 3 quinine cyclol
CN104496842B (en) preparation method of hindered phenol antioxidant 1019
JP2008143857A (en) Method for producing benzofluorene derivative and its intermediate
CN112225739B (en) Preparation method of azetidine compound
CA2910011A1 (en) A process for preparing ivabradine
CN110407676B (en) Synthetic method and application of diphenylethanedione compound
CN107089918B (en) Preparation method of benzhydrylamine hydrochloride
CN110452139B (en) Preparation method of 2-methyl-3-bromo-6-methylsulfonyl benzonitrile
CN107501061A (en) A kind of preparation method of the ketone of 2 methoxyl group, 6,7,8,9 tetrahydro benzo cycloheptane 5
CN100357245C (en) Prepn process of 2,5-dihalogeno benzoic acid
CN110790679B (en) Preparation method of 3-bromopropionitrile
CN107652195A (en) A kind of preparation method of 1 amino cyclopropanecarboxylic acid
CN102976993A (en) Synthetic method of 3-hydroxyazetidine hydrochloride
CN105294679A (en) Preparation method for praziquantel
AU2022369156A1 (en) A process for the preparation of 2,7-dihydroxy-9-fluorenone useful for the synthesis of tilorone and its salts
CN103288710A (en) Preparation method of trandolapril midbody (2S, 3aR, 7aS)-octahydro-1H-indole-2-carboxylic acid

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20150922

Address after: Wenjiang District 611130 of Sichuan city of Chengdu province Chengdu Strait science and Technology Industry Development Park No. 488 West Ke Lin Lu

Patentee after: ASTATECH (CHENGDU) PHARM. CO., LTD.

Address before: High tech Zone Gaopeng road in Chengdu city of Sichuan province in 610041 No. 5 students Pioneering Park East (Chengdu) Medical Technology Co Ltd

Patentee before: AstaTech (Chengdu) Pharmaceutical Co., Ltd.

C56 Change in the name or address of the patentee
CP03 Change of name, title or address

Address after: Wenjiang District 610000 of Sichuan city of Chengdu province Chengdu Strait science and Technology Industry Development Park No. 488 West Ke Lin Lu

Patentee after: Astatech (Chengdu) biological pharmaceutical Limited by Share Ltd

Address before: Wenjiang District 611130 of Sichuan city of Chengdu province Chengdu Strait science and Technology Industry Development Park No. 488 West Ke Lin Lu

Patentee before: ASTATECH (CHENGDU) PHARM. CO., LTD.

PE01 Entry into force of the registration of the contract for pledge of patent right

Denomination of invention: Synthetic method of 7 or 9-chloro-4,5-dihydro-1hydro-benzo[b]azepine-2(3hydro)-one

Effective date of registration: 20170822

Granted publication date: 20150401

Pledgee: Chengdu SME financing Company Limited by Guarantee

Pledgor: Astatech (Chengdu) biological pharmaceutical Limited by Share Ltd

Registration number: 2017510000052

PE01 Entry into force of the registration of the contract for pledge of patent right
PC01 Cancellation of the registration of the contract for pledge of patent right

Date of cancellation: 20180801

Granted publication date: 20150401

Pledgee: Chengdu SME financing Company Limited by Guarantee

Pledgor: Astatech (Chengdu) biological pharmaceutical Limited by Share Ltd

Registration number: 2017510000052

PC01 Cancellation of the registration of the contract for pledge of patent right